FT BBG R&D Leaders ETFRNDETF
13F holders, Q3 2025 (September 30)4holders +1
1new positions
0sold out
$29.63avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding FT BBG R&D Leaders ETF (RND) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Concentrum Wealth Management ($266K), IFP Advisors, Inc ($135K) and Tower Research Capital LLC (TRC) ($42K).
- Company
- FT BBG R&D Leaders ETF
- Filed as
- FIRST TR EXCHANGE TRADED FD (Q3 2025)
- CUSIP
- 33738R621
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 128 shares bought and 2,733 shares sold, net −2,605 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Concentrum Wealth Management | 0.08% | No change | 8,985 | $266K |
| IFP Advisors, Inc | 0.00% | Reduce -3.6% | 4,568 | $135K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -64.3% | 1,426 | $42K |
| UBS Group AG | 0.00% | New | 128 | $4K |
"% of holder's portfolio" is RND's weight in each manager's 13F, not the share of FT BBG R&D Leaders ETF the manager owns.